EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis
EULAR proposes 2 consensus definitions to identify a D2M PsA population, including a TR subgroup. These definitions should now be tested in research studies to understand disease pathogenesis and improve care for people living with PsA.
Authors
- Enrique Roberto Soriano (ORCID: https://orcid.org/0000-0003-3143-1084)
- Maria Sole Chimenti (ORCID: https://orcid.org/0000-0002-1343-1729)
- Sibel Zehra Aydın (ORCID: https://orcid.org/0000-0001-8792-4449)
- L. Puig (ORCID: https://orcid.org/0000-0001-6083-0952)
- Andra Rodica Balanescu (ORCID: https://orcid.org/0000-0003-0688-9173)
- Filip Van den Bosch (ORCID: https://orcid.org/0000-0002-3561-5932)
- Stephanie R Harrison (ORCID: https://orcid.org/0000-0002-7465-2621)
- Christine Bundy (ORCID: https://orcid.org/0000-0002-5981-3984)
- György Nagy (ORCID: https://orcid.org/0000-0003-1198-3228)
- Rubén Queiró (ORCID: https://orcid.org/0000-0002-8418-7145)
- Cristina Clara Macía Villa (ORCID: https://orcid.org/0000-0002-6822-6730)
- Helena Marzo‐Ortega (ORCID: https://orcid.org/0000-0002-9683-3407)
- Russka Shumnalieva (ORCID: https://orcid.org/0000-0003-2321-6536)
- Stefan Siebert (ORCID: https://orcid.org/0000-0002-1802-7311)
- George E. Fragoulis (ORCID: https://orcid.org/0000-0003-4932-7023)
- Heidi Bertheussen (ORCID: https://orcid.org/0000-0001-6693-9254)
- Xabier Michelena (ORCID: https://orcid.org/0000-0002-5352-919X)
- Pedro Machado (ORCID: https://orcid.org/0000-0002-8411-7972)
- Bente Glintborg (ORCID: https://orcid.org/0000-0002-8931-8482)
- Umut Kalyoncu (ORCID: https://orcid.org/0000-0001-7129-2109)
- Alexandre Rocha Sepriano (ORCID: https://orcid.org/0000-0003-1954-0229)
- Laure Gossec (ORCID: https://orcid.org/0000-0002-4528-310X)
- Wendy Wagenaar
- Ennio Lubrano (ORCID: https://orcid.org/0000-0002-8050-9637)
- Proton Rahman
- Paolo Gisondi
- Merle A. Sande
Institutions
- Semmelweis University (HU)
- University of Rome Tor Vergata (IT)
- University of Verona (IT)
- Universitat Autònoma de Barcelona (ES)
- University of Molise (IT)
- Memorial University of Newfoundland (CA)
- University of Ottawa (CA)
- Inserm (FR)
- Carol Davila University of Medicine and Pharmacy (RO)
- Tilburg University (NL)
- Instituto Cajal (ES)
- London North West Healthcare NHS Trust (GB)
- Ottawa Hospital (CA)
- Ghent University Hospital (BE)
- Hospital de Sant Pau (ES)
- Glostrup Hospital (DK)
- Hospital Italiano de Buenos Aires (AR)
- Copenhagen University Hospital (DK)
- Medical University of Sofia (BG)
- National Institute for Health and Care Research (GB)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- NIHR Leeds Musculoskeletal Biomedical Research Unit (GB)
- Vall d'Hebron Hospital Universitari (ES)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Hospital Universitario Central de Asturias (ES)
- VIB-UGent Center for Inflammation Research (BE)
- University College London (GB)
- Hacettepe University (TR)
- Athens State University (US)
- University of Glasgow (GB)
- Cardiff University (GB)
- Universidade Nova de Lisboa (PT)
- University of Amsterdam (NL)
Publication Details
- Journal
- Annals of the Rheumatic Diseases
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1016/j.ard.2025.10.002
- Citations
- 8
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 13.34
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Biogen
- Teva Pharmaceutical Industries
- Celgene
- Celltrion
- National Institute for Health and Care Research
- University College London
- University College London Hospitals NHS Foundation Trust
- Teijin Pharma
- Swedish Orphan Biovitrum
- Samsung
- Leeds Biomedical Research Centre